ArticlePharmacological reports : PR2026

The PERK inhibitor GSK2606414 evokes developmental defects in zebrafish consistent with Wolcott-Rallison syndrome phenotypes.

Liliana M Almeida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.